Atlas Trials

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

Clinical trial NCT00224263 · COMPLETED

Trial details

NCT number
NCT00224263
Sponsor
Xuanwu Hospital, Beijing
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease
Start date
2005-09-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.